Best of MS: AAN 2017
The four top-scoring MS abstracts submitted for AAN 2017 included 6-year outcomes with alemtuzumab treatment and pediatric MS environmental risk factors.
Interesting Neuro: New Drugs & TBI Recovery
April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.
Interesting Neuro: Tumor Tx and Stroke Recovery
March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.
Neuro News Roundup: Parkinson or parkinsonian?
Studies also include stem cell transplantation for treatment-refractory MS and aspirin use for headache to lessen the need for rescue medication.
ACTRIMS 2017 Forum: MS Treatment Clinical Trials
Research examined no evidence of disease activity and no evidence of progression with ocrelizumab as well as long-term results with mitoxantrone.
Top 10 Neurology Apps
Ten general and disease-specific apps for neurologists include assessment scales, anatomical diagrams, and interactive clinical decision support.
Interesting Neuro: Stroke Risks & Treatment
February news includes stroke risk with Alzheimer disease & migraine, neonatal hemorrhagic stroke, and head trauma in sports.
By clicking Accept, you agree to become a member of the UBM Medica Community.